Azathioprine and Riluzole share 14 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.241 means 24% of the combined target set is bound by both compounds. The IDF-weighted score of 0.178 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Azathioprine and Riluzole have in common?
Azathioprine and Riluzole share 14 molecular targets with a Jaccard similarity of 24%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Azathioprine and Riluzole be combined?
Azathioprine and Riluzole share 14 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Azathioprine or Riluzole?
Both Azathioprine and Riluzole have substantial PubMed research. View their individual profiles for full evidence scores.